Is Kineta, Inc. (KA) a Buy, Sell, or Hold?
NASDAQ : KA
Kineta, Inc.
$0.5746 USD
-$0.26 (-30.77%)
- Volume
- 480.68K
- Average Volume
- 508.86K
- Market Capitalization
- $7.05M
- P/E Ratio
- -0.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.39
- Year Low
- $0.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.08
Company Overview
NASDAQ
Craig W. Philips
Biotechnology
Healthcare
KA
11
US
USD
Liquidity Metrics
-0.05
0.08
0.08
0.05
0.00
Sales & Valuation
-$
0.00
-0.58
-0.61
-0.96
Profitability
-$1.42
-$17.13M
0.00%
0.00%
374.84%
-1681.26%
P/E Metrics
-0.40
-0.01
-0.01
Analyst Price Target & Rating
0/5
1 Analysts
%
Financial Health Scores
-353.49
3/9
-$13.19M
$842K
$14.04M
-$8.47M
Key Metrics (TTM)
$7.04M
0.00
-0.52
0.08
374.84%
120.41%
-246.41%
-164.18%
0 days
Company Executives
| Name | Title |
|---|---|
| Pauline Kenny | Advisor |
| Gary Gentges | Executive Vice President of Corporate Development |
| Keith Baker | Chief Financial Officer |
| Craig W. Philips | President & Secretary |
| Thierry Guillaudeux | Chief Scientific Officer |
Poll Results
No votes yet today — be the first to share your view!
About Kineta, Inc. (NASDAQ:KA) Stock
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington. ...
Frequently Asked Questions
-
What is the current Kineta, Inc. (KA) stock price?
-
Kineta, Inc.(NASDAQ:KA) stock price is $0.5746 in the last trading session. During the trading session, KA stock reached the peak price of $5.39 while $0.3339 was the lowest point it dropped to. The percentage change in KA stock occurred in the recent session was --30.77% while the dollar amount for the price change in KA stock was -$0.26.
-
KA's industry and sector of operation?
-
The NASDAQ listed KA is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of KA?
-
Pauline Kenny | Advisor
Gary Gentges | Executive Vice President of Corporate Development
Keith Baker | Chief Financial Officer
Craig W. Philips | President & Secretary
Thierry Guillaudeux | Chief Scientific Officer -
How many employees does KA have?
-
Number of KA employees currently stands at 11. KA operates from 219 Terry Ave. N, Seattle, WA 98109, US.
-
Link for KA official website?
-
Official Website of KA is: https://kinetabio.com
-
How do I contact KA?
-
KA could be contacted at phone #206 378 0400 and can also be accessed through its website. KA operates from 219 Terry Ave. N, Seattle, WA 98109, US.
-
How many shares of KA are traded daily?
-
The average number of KA shares traded daily for last 3 months was 508.86K.
-
What is the market cap of KA currently?
-
The market value of KA currently stands at $7.05M with its latest stock price at $0.5746